MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹1,727 Cr | ₹1,473 Cr | ₹1,334 Cr | ₹845 Cr | ₹604 Cr |
What is the latest Net Current Assets ratio of MARKSANS PHARMA ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹1,727 Cr |
| Mar2024 | ₹1,473 Cr |
| Mar2023 | ₹1,334 Cr |
| Mar2022 | ₹845 Cr |
| Mar2021 | ₹604 Cr |
How is Net Current Assets of MARKSANS PHARMA Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,727 Cr | 17.26 | |
| Mar2024 | ₹1,473 Cr | 10.37 | |
| Mar2023 | ₹1,334 Cr | 57.91 | |
| Mar2022 | ₹845 Cr | 39.93 | |
| Mar2021 | ₹604 Cr | - | |
Compare Net Current Assets of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹12,213.7 Cr | 3.2% | 8% | 3.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,644.0 Cr | 1.1% | 7.2% | 15.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹184,053.0 Cr | 2.4% | 4.2% | -1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹167,464.0 Cr | 1.9% | 8.3% | 45.6% | Stock Analytics | |
| CIPLA | ₹115,263.0 Cr | -1.8% | 3.2% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,049.0 Cr | -8.8% | -3.2% | -4.6% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | 3.2% |
8% |
3.6% |
| SENSEX | -0.9% |
4.9% |
-6.8% |
You may also like the below Video Courses